PLx Pharma Inc.
PLXPNASDAQHealthcare
$0.09
+$0.00(+0.00%)
Market Cap$2534980
P/E Ratio—
52W High$3.41
52W Low$0.009
PLx Pharma Inc. (PLXP) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PLXP · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2023Report Date: Mar 10, 2023EPS Actual
-$0.73
Est. -$0.28 · -160.7%
Revenue
—
Est. $0.00B
Fiscal Period
Q1 FY2023
FY ends December
Report Date
Mar 10, 2023
After Market Close
▼ Miss EPS
PLXP reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2023 | Nov 9, 2023 | — | — | — | — | — | — |
| ◌ Q3 FY2023 | Aug 10, 2023 | -$0.28 | — | — | — | $0.00B | — |
| ◌ Q2 FY2023 | Apr 3, 2023 | -$0.28 | — | — | — | $0.00B | — |
| ▼ Q1 FY2023 | Mar 10, 2023 | -$0.28 | -$0.73 | -160.7% | — | $0.00B | — |
| ▲ Q4 FY2022 | Nov 10, 2022 | -$0.44 | -$0.37 | +15.9% | $0.00B | — | — |
| ▲ Q3 FY2022 | Aug 12, 2022 | -$0.56 | -$0.52 | +7.1% | $0.00B | — | — |
| ▲ Q2 FY2022 | May 13, 2022 | -$0.69 | -$0.66 | +4.3% | $0.00B | $0.00B | -23.8% |
| ▼ Q1 FY2022 | Mar 11, 2022 | -$0.69 | -$0.73 | -5.8% | $0.00B | $0.00B | -59.2% |
Q4 FY2023
Nov 9, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 10, 2023
EPS Actual
—
EPS Est.
-$0.28
EPS Surpr.
—
Revenue
—
Q2 FY2023
Apr 3, 2023
EPS Actual
—
EPS Est.
-$0.28
EPS Surpr.
—
Revenue
—
Q1 FY2023
Mar 10, 2023Miss
EPS Actual
-$0.73
EPS Est.
-$0.28
EPS Surpr.
-160.7%
Revenue
—
Q4 FY2022
Nov 10, 2022Beat
EPS Actual
-$0.37
EPS Est.
-$0.44
EPS Surpr.
+15.9%
Revenue
$0.00B
Q3 FY2022
Aug 12, 2022Beat
EPS Actual
-$0.52
EPS Est.
-$0.56
EPS Surpr.
+7.1%
Revenue
$0.00B
Q2 FY2022
May 13, 2022Beat
EPS Actual
-$0.66
EPS Est.
-$0.69
EPS Surpr.
+4.3%
Revenue
$0.00B
Q1 FY2022
Mar 11, 2022Miss
EPS Actual
-$0.73
EPS Est.
-$0.69
EPS Surpr.
-5.8%
Revenue
$0.00B
No analyst estimates available for PLXP.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2023 | Mar 10, 2023 | -160.7% | $0.17 | $0.16 | -7.91% |
| ▲ Q4 FY2022 | Nov 10, 2022 | +15.9% | $0.59 | $0.60 | +1.69% |
| ▲ Q3 FY2022 | Aug 12, 2022 | +7.1% | $2.59 | $1.64 | -36.68% |
| ▲ Q2 FY2022 | May 13, 2022 | +4.3% | $2.03 | $2.59 | +27.59% |
| ▼ Q1 FY2022 | Mar 11, 2022 | -5.8% | $4.38 | $4.05 | -7.53% |
| ▲ Q4 FY2021 | Nov 12, 2021 | +21.3% | $13.04 | $12.28 | -5.83% |
| ▼ Q3 FY2021 | Aug 6, 2021 | -60.9% | $18.44 | $19.09 | +3.52% |
| ▼ Q2 FY2021 | May 14, 2021 | -47.1% | $9.80 | $11.07 | +12.96% |
Q1 FY2023-7.91%
Report Date
Mar 10, 2023
EPS Beat/Miss
-160.7%
Price Before
$0.17
Price After
$0.16
Q4 FY2022+1.69%
Report Date
Nov 10, 2022
EPS Beat/Miss
+15.9%
Price Before
$0.59
Price After
$0.60
Q3 FY2022-36.68%
Report Date
Aug 12, 2022
EPS Beat/Miss
+7.1%
Price Before
$2.59
Price After
$1.64
Q2 FY2022+27.59%
Report Date
May 13, 2022
EPS Beat/Miss
+4.3%
Price Before
$2.03
Price After
$2.59
Q1 FY2022-7.53%
Report Date
Mar 11, 2022
EPS Beat/Miss
-5.8%
Price Before
$4.38
Price After
$4.05
Q4 FY2021-5.83%
Report Date
Nov 12, 2021
EPS Beat/Miss
+21.3%
Price Before
$13.04
Price After
$12.28
Q3 FY2021+3.52%
Report Date
Aug 6, 2021
EPS Beat/Miss
-60.9%
Price Before
$18.44
Price After
$19.09
Q2 FY2021+12.96%
Report Date
May 14, 2021
EPS Beat/Miss
-47.1%
Price Before
$9.80
Price After
$11.07
Avg Beat Reaction-3.31%
Avg Miss Reaction+0.26%
Beat Rate4 / 8 quarters
Largest Move-36.68% (Q3 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PLXP ends December
PLx Pharma Inc. (PLXP) most recently reported earnings on March 10, 2023 for Q1 FY2023, posting EPS of $-0.73 — missing the analyst consensus of $-0.28 by -160.7%. The next PLXP earnings date is expected around September 1, 2026.
Each quarter, investors track PLXP earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PLXP revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PLXP's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PLXP earnings · 5 questionsPLx Pharma Inc.'s next earnings report is expected around September 1, 2026. PLXP typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PLXP historically reports after market close (AMC).
PLXP earnings datewhen is PLXP earningsPLXP next earnings datewhen does PLXP report earningsPLXP earnings calendar
▸ Source: FMP · PLx Pharma Inc. SEC filings · US GAAP · PLx Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026